REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,817 | -85.9% | 24 | -76.2% | 0.00% | -100.0% |
| Q4 2021 | $27,000 | -6.9% | 101 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $29,000 | +866.7% | 101 | +531.2% | 0.00% | – |
| Q2 2021 | $3,000 | -98.9% | 16 | -98.8% | 0.00% | -100.0% |
| Q1 2021 | $267,000 | -7.0% | 1,375 | -8.1% | 0.01% | -16.7% |
| Q4 2020 | $287,000 | +28.7% | 1,497 | -1.0% | 0.01% | +20.0% |
| Q3 2020 | $223,000 | +3616.7% | 1,512 | +2807.7% | 0.01% | – |
| Q2 2020 | $6,000 | +20.0% | 52 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -16.7% | 52 | -16.1% | 0.00% | – |
| Q4 2019 | $6,000 | 0.0% | 62 | -18.4% | 0.00% | – |
| Q3 2019 | $6,000 | -45.5% | 76 | -41.1% | 0.00% | -100.0% |
| Q2 2019 | $11,000 | +22.2% | 129 | -13.4% | 0.00% | 0.0% |
| Q1 2019 | $9,000 | +125.0% | 149 | +49.0% | 0.00% | – |
| Q4 2017 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |